OLMSTED SYNDROME

Clinical trials for OLMSTED SYNDROME explained in plain language.

Never miss a new study

Get alerted when new OLMSTED SYNDROME trials appear

Sign up with your email to follow new studies for OLMSTED SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill could ease rare skin disease

Disease control Recruiting now

This early-stage trial tests an oral drug called KM-023 for Olmsted Syndrome, a rare genetic condition causing painful, thick skin on the palms and soles. First, healthy volunteers will receive single or multiple doses to check safety and how the body handles the drug. Then, pati…

Matched conditions: OLMSTED SYNDROME

Phase: PHASE1 • Sponsor: Orvida Pharma (formerly Kamari Pharma) • Aim: Disease control

Last updated Jun 27, 2026 12:36 UTC

OLMSTED SYNDROME

Get alerted when new OLMSTED SYNDROME trials appear

New pill could ease rare skin disease